Inflammation-mediated damage in progressing lacunar infarctions a potential therapeutic target

Stroke

Volumn 33, Issue 4, 2002, Pages 982-987

  Castellanos, Mar ^a   Castillo, José ^b   García, María M ^a   Leira, Rogelio ^b   Serena, Joaquín ^a   Chamorro, Angel ^c   Dávalos, Antoni ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Cytokines; Inflammation; Lacunar infarction; Stroke outcome

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAIN INFARCTION; BRAIN INJURY; BRAIN VENTRICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RATING SCALE;

AGED; BIOLOGICAL MARKERS; BRAIN INFARCTION; DISEASE PROGRESSION; ENCEPHALITIS; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036214866     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/hs0402.105339     Document Type: Article

References (49)

1. Lacunar strokes and infarcts: A review
2. Pure motor hemiplegia: CT study of 30 cases
3. Lacunar infarcts: Clinical and computed tomographic correlations
4. Progressive stroke caused by CT-verified small deep infarcts; relation with the size of the infarct and clinical outcome
5. Conical features of progressive lacunar infarction: Retrospective analysis of patients with motor syndromes
6. Progressive motor deficits in lacunar infarction
7. Different predictors of neurological worsening in different causes of stroke
8. Ischemic stroke subtypes: A population-based study of functional outcome, survival, and recurrence
9. Inflammatory mediators and brain injury: The role of cytokines and chemokines in stroke and CNS diseases
10. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats
11. Tumor necrosis factor-α: A mediator of focal ischemic brain injury
12. Interleukin-1β expression in ischemic rat cortex
13. Tumor necrosis factor-α in ischemic neurons
14. Concomitant cortical expression of TNF α and IL-1β mRNA following transient focal ischemia
15. Expression of interleukin-6, c-fos and zif268 mRNA in rat ischemic cortex
16. Upregulation of intracellular adhesion molecule-1 on brain microvascular endothelial cells in ischemic cortex
17. Role of cell adhesion molecules in brain injury after middle cerebral artery occlusion in the rat
18. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion
19. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: Kinetics of secretion and relation to the extent of brain damage and outcome of disease
20. Increased cytokine release from peripheral blood cells after acute stroke
21. Intrathecal release of pro- and anti-inflammatory cytokines during stroke
22. Early intrathecal production of interleukin-6 predicts the volume of brain lesion in stroke
23. A longitudinal prospective study of soluble adhesion molecules in acute stroke
24. Circulating intercellular adhesion molecule-1 levels and neutrophil adhesion in stroke
25. Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke
26. Cytokine-induced inflammation and long-term stroke functional outcome
27. Proinflammatory cytokines and early neurological worsening in ischemic stroke
28. The initial acute phase response predicts long term stroke recovery
29. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases
30. Neurological deterioration in acute lacunar infarctions: The role of excitatory and inhibitory neurotransmitters
31. The natural history of lacunar infarction: The Oxfordshire Community Stroke Project
32. The Canadian Neurological Scale: Validation and reliability assessment
33. Use of Barthel Index and modified Rankin Scale in acute stroke trials
34. Formulas for threshold computations
35. Mechanism in progressive lacunar infarction: Case report with magnetic resonance imaging
36. Cytokines, inflammation, and brain injury: Role of tumor necrosis factor-α
37. Imaging of leukocyte accumulation in human cerebral infarcts
38. Dynamic of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage
39. Evolution of cerebral tumor necrosis factor-α production during human ischemic stroke
40. The expression of adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis
41. Anatomy and physiology of glutamate in the CNS
42. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures
43. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat
44. Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage
45. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial
46. Does platelet antiaggregant therapy lessen the severity of stroke?
47. Neuroprotective effects of aspirin in acute ischemic stroke
48. Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats
49. Role of nuclear factor kappa B in neuropathological mechanisms